Prevalence of hepatitis B and C markers in volunteer blood donors in Crete. A 5-year study

Journal of Viral Hepatitis

Volumn 6, Issue 3, 1999, Pages 243-248

  Koulentaki, M ^a   Spanoudakis, S ^a   Kantidaki, E ^a   Drandakis, P ^b   Tzagarakis, N ^c   Biziagos, E ^a   Moschandrea, J ^d   Kouroumalis, E A ^a,e  

^a UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

^b Rethymnon District General Hospital   (Greece)

^c Chania General Hospital   (Greece)

^d UNIVERSITY OF CRETE   (Greece)

^e UNIVERSITY HOSPITAL OF IRAKLION   (Greece)

Author keywords

Blood donors; Hepatitis B; Hepatitis C

Indexed keywords

HEPATITIS B CORE ANTIBODY; HEPATITIS B CORE ANTIGEN; HEPATITIS B SURFACE ANTIGEN;

AGE DISTRIBUTION; ARTICLE; BLOOD DONOR; ENDEMIC DISEASE; FEMALE; GEOGRAPHIC DISTRIBUTION; GREECE; HEPATITIS B; HEPATITIS C; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEROPREVALENCE; SEX DIFFERENCE; VIRUS DIAGNOSIS; VIRUS TRANSMISSION;

BIOLOGICAL MARKERS; BLOOD DONORS; FEMALE; GREECE; HEPACIVIRUS; HEPATITIS ANTIBODIES; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B CORE ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; MALE; PREVALENCE;

EID: 0032974627     PISSN: 13520504     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2893.1999.00155.x     Document Type: Article

References (27)

1. National Statistical Service of Greece (Eds). Social Welfare and Health Statistics, 1986. Athens, 1989.
2. National Statistical Service of Greece (Eds). Social Welfare and Health Statistics, 1988. Athens, 1991.
3. National Statistical Service of Greece (Eds). Social Welfare and Health Statistics, 1991. Athens, 1994.
4. Kouroumalis EA, Skordilis P, Moschandrea J et al. Natural history of advanced hepatocellular carcinoma in Crete. Association with hepatitis C virus. Eur J Gastroenterol Hepatol 1997; 9: 981-988.
5. Vlachonicolis I, Georgoulias B. Mortality from malignancies in Crete. Iatriki 1996; 69: 291-302.
6. Armitage P, Berry G. Statistical Methods in Medical Research, 2nd edn. Oxford: Blackwell Scientific Publications, 1987: 207.
7. Armitage P, Berry G. Statistical Methods in Medical Research, 2nd edn. Oxford: Blackwell Scientific Publications, 1987: 124.
8. Armitage P, Berry G. Statistical Methods in Medical Research, 2nd edn. Oxford: Blackwell Scientific Publications, 1987: 381.
9. Armitage P, Berry G. Statistical Methods in Medical Research, 2nd edn. Oxford: Blackwell Scientific Publications, 1987: 458.
10. Agresti A. An Introduction to Categorical Data Analysis. Wiley Series in Probability and Statistics, Wiley: New York 1996: 21.
11. Tassopoulos NC, Papatheodoridis GV. Epidemiology of hepatitis B virus infection. Hellenic J Gastroenterol 1993; 6: 67-73.
12. Struve J, Giesecke J, Olcen P, von Sydow M, Weiland O. Prevalence of hepatitis B virus markers in Sweden: a community-based serosurvey of 4000 young Swedish adults. Am J Epidemiol 1992; 135: 409-417.
13. Banke O, Dybkjaer E, Nordfelt E et al. Australia antigen and antibody in 10000 Danish blood donors. Lancet 1971; 1: 860-861.
14. Hansson BG, Sundstrom G, Johnsson T. Occurrence of hepatitis B surface antigen (HBsAg) in blood donors and patients suffering from transfusion hepatitis. Acta Pathol Microbiol Immunol Scand Sect C 1975; 83: 112-120.
15. Iwarsson S, Lindholm A, Lundin P et al. Hepatitis associated antigen and antibody in Swedish blood donors. Relation to liver disease. Vox Sang 1972; 22: 501-509.
16. Papatheodoridis GV, Tassopoulos NC. Epidemiology of hepatitis C virus. Iatriki 1993; 64: 504-512.
17. Lionis C, Koulentaki M, Biziagos E, Kouroumalis E. Current prevalence of hepatitis A,B,C in a well-defined area in rural Crete, Greece. J Viral Hep 1997; 4: 55-61.
18. Gonzalez A, Esteban JI, Madoz P et al. Efficacy of screening donors for antibodies to hepatitis C virus to prevent transfusion-associated hepatitis: final report of a prospective trial. Hepatology 1995; 22: 439-445.
19. Munoz-Gomez R, Garcia Mouzou CO, García-Bney L et al. Hepatitis C virus infection in Spanish volunteer blood donors: HCV RNA analysis and liver disease. Eur J Gastroenterol Hepatol 1996; 8: 273-277.
20. Salmeron FJ, Palacios A, Perez-Ruiz M et al. Epidemiology, serological markers and hepatitic disease of anti-HCV ELISA 2 positive blood donors. Dig Dis Sci 1996; 41: 1933-1998.
21. De Luca M, Ascione A, Vacca C, Zarone A. Are health-care workers really at risk of HCV infection? Letter. Lancet 1992; 339: 1364-1365.
22. Parota M, Deloro K, Giordano M et al. Prevalence of anti-HCV in blood donors. Ital J Gastroenterol 1996; 23: 555-558.
23. El Gohary A, Hassan A, Nooman Z et al. High prevalence of hepatitis C virus among urban and rural population groups in Egypt. Acta-Trop 1995; 59: 155-161.
24. Bar Shany S, Green MS, Slepon R, Shinar E. Ethnic differences in the prevalence of anti-hepatitis C antibodies and hepatitis B surface antigen in Israeli blood donors by age, sex, country of birth and origin. J Viral Hep 1995; 2: 139-144.
25. Caspari G, Gerlich WH, Beyer J, Schmitt H. Age, sex and transaminase dependency of specific and non-specific results from enzyme immunoassays for antibodies to hepatitis C virus and follow-up of blood donors. Infusion Ther Transfusion Med 1995; 22: 208-219.
26. Mutimer DJ, Harrison RF, O'Donnell KB et al. Hepatitis C virus infection in the asymptomatic British blood donor. J Viral Hep 1995; 2: 47-53.
27. Watson JP, Brind AM, Chapman CE et al. Hepatitis C virus: epidemiology and genotypes in the North East of England. Gut 1996; 38: 269-276.